C[C@H]1C[C@H](C)C(=O)[C@H]([C@@H](C)CC2CC(=O)NC(=O)C2)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?